Promea promises a wide range of support.
Promea Therapeutics is an innovative medical device
manufacturing company specializing in Life Sciences, Diagnostics
which includes Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics and Infusion Therapies.
We believe that "A picture is worth a thousand words & a video is worth a million emotions". We are presenting handpicked collection of various snaps and video clips connected with Promeans & Promea's products.
We firmly believe that the technology should support people and people should focus on what matters. Embarking our
journey, we have successfully adopted & developed many unique products embedded with diverse technologies.
We're also pleased to have earned different ISO certifications for internal quality standards and good manufacturing practices, as well as recognitions for our focus on producing products that encourage our manufacturing capability & environmental sustainability.
We believe that the people behind a company are as important as the company itself. You're likely to find that kind of personalities who have brought the wealth of skills and experience from a wide range of backgrounds.
Promea's Electrolyte is world's most Innovative and affordable solution for mid size laboratories.
Promea catering the needs of efficient labs with world's most efficient Hematology Analyzers.
Promea's Semi Automated Biochemistry Analyzer is one of the maintenance free semi auto analyzer.
Promea is delivering Point Of Care Immuno Assay products
embedded with advanced technologies.
Promea has developed & commercialized the affordable
& connected glucose meter solutions.
Promea dedicates the development of Hemoglobin Meter to Anemia Mukt Bharat
Promea covers wide range of infectious rapids as well as specialty parameters of rapids.
Promea bringing the affordable automation to
compliment the productivity of Elisa Kits.
Promea has developed diverse range of RT-PCR
solutions to cater the testing needs
Promea's unique range of Biologics produces various parameters of injectables.
Promea is developing user friendly products prioritizing the Home Health Care.
Promea has indigenously developed lot of ancillary products to cater various diagnostic testing needs.
Promea manufactures a wide range of High Quality Fluid Therapy Products.
At Promea we're building a global team of amazing people. If you're curious, ambitions and ready to grow your career with us, we'd love to meet you !
We introduce the activities of the R&D Center, the
core of PROMEA.
The true testament of any great skyscraper is its strong and sustainable foundation. That’s what we’ve been building at Promea. These 5 years have truly been a whirlwind of exciting growth and opportunity. When I reflect upon Promea’s journey, I cannot help feeling proud of what we’ve managed to accomplish given the circumstances.
Exactly 2.5 years ago, midway into our establishment journey, the world halted with the looming pandemic - COVID-19. Promea was hit harder than most, at that point in time we were 50% finished with our facilities and the market had pivoted so fast, that we had to make quick consequential decisions. If we measure success beyond a spreadsheet, it’s exciting to see that Promea grew strengths and experiences that only a pandemic of that scale can bring.
In these 5 years we’ve established a diagnostic portfolio of more than 75 products and have completed an infusion therapies manufacturing facility that has one of the largest manufacturing capacities in South India.
These next 5 years, I’m excited to see Promea cement itself in the Indian market with our robust products and scale to international markets where our products can be appreciated for their quality and effectiveness.
All of what we have achieved could never have been possible without our family - Promea’s employees - both past and current. I hope to continue this journey and cultivate strong pillars that can take us to the next level.
I am thankful for every second of this 5 year journey, it has truly been a fulfilling experience and I look towards the horizon for the next 5.